Results 151 to 160 of about 151,084 (348)

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

CO-MORBIDITY AND FORECASTING THE RISK OF POST-OPERATIVE INFECTIOUS COMPLICATIONS IN TUBERCULOUS SPONDYLITIS PATIENTS

open access: yesТуберкулез и болезни лёгких, 2016
Goal of the study: to study co-morbidity and risk of post-operative infectious complications in tuberculous spondylitis patients with concurrent non-specific spinal osteomyelitis as per ASA, PITSS scales and Charlson score.Materials and methods. Surgical
S. V. Burlakov, A. A. Vishnevskiy
doaj   +1 more source

How accurate is your sclerostin measurement?:Comparison between three commercially available sclerostin ELISA kits [PDF]

open access: yes, 2016
Sclerostin, bone formation antagonist is in the spotlight as a potential biomarker for diseases presenting with associated bone disorders such as chronic kidney disease (CDK-MBD). Accurate measurement of sclerostin is therefore important.
Fisher, Emily   +6 more
core   +1 more source

Prevalence, treatment and burden of chronic spontaneous urticaria in five European countries

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluates prevalence, treatment patterns, disease profile and burden in patients with chronic spontaneous urticaria (CSU) in five European countries (EU5: France, Germany, Italy, Spain and the United Kingdom [UK]). CU, chronic urticaria; ER, emergency room; GAD, General Anxiety Disorder‐7; HRU, healthcare resource use; HRQoL, health‐related ...
Maria‐Magdalena Balp   +8 more
wiley   +1 more source

Outcomes of treatment in 50 cases with spinal brucellosis in Babol, Northern Iran

open access: yesJournal of Infection in Developing Countries, 2012
Introduction: Duration of treatment for brucellar spondylitis in endemic regions is controversial. This study describes the outcome of treatment in 50 cases of brucellar spondylitis in Iran.
Seyed Mokhtar Smailnejad Gangi   +5 more
doaj   +1 more source

The Dental Status of Patients Taking Common Biologic Agents: A Single‐Center Cross‐Sectional Study

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives Despite expanding use and medical applications, little is known about the impact of biologic agents (BAs) on dental treatment. The aim of this study was to investigate the dental status of patients on common classes of BAs to understand treatment needs and use in this population.
Shivani Shah   +4 more
wiley   +1 more source

Grupos educacionais para pacientes com espondilite anquilosante: revisão sistemática

open access: yesRevista Dor
JUSTIFICATIVA E OBJETIVOS: A espondilite anquilosante (EA) é uma doença inflamatória, crônica, que acomete as articulações sacroilíacas, em graus variáveis a coluna vertebral e, em menor extensão as articulações periféricas.
Marcelo Cardoso de Souza   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy